Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
16.56
-1.38 (-7.69%)
Apr 3, 2025, 4:00 PM EDT - Market closed

Travere Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
1,4701,5166761,3501,9001,391
Upgrade
Market Cap Growth
124.43%124.43%-49.94%-28.99%36.59%128.10%
Upgrade
Enterprise Value
1,5001,6414461,2511,6091,177
Upgrade
Last Close Price
16.5617.428.9921.0331.0427.25
Upgrade
PS Ratio
5.606.504.6512.3314.427.02
Upgrade
PB Ratio
24.5125.663.3631.496.296.59
Upgrade
P/TBV Ratio
--7.01-12.3724.37
Upgrade
EV/Sales Ratio
6.437.043.0711.4312.215.93
Upgrade
Debt / Equity Ratio
6.806.802.029.510.871.16
Upgrade
Asset Turnover
0.340.340.200.150.190.33
Upgrade
Inventory Turnover
28.8628.8636.8139.1627.4820.15
Upgrade
Quick Ratio
1.991.993.333.304.594.26
Upgrade
Current Ratio
2.082.083.473.424.704.43
Upgrade
Return on Equity (ROE)
-246.75%-246.75%-308.90%-192.18%-84.66%-78.37%
Upgrade
Return on Assets (ROA)
-23.15%-23.15%-32.22%-27.58%-18.01%-7.77%
Upgrade
Return on Capital (ROIC)
-30.03%-30.03%-44.60%-39.41%-24.45%-10.69%
Upgrade
Earnings Yield
-21.88%-21.21%-16.49%-20.64%-9.48%-12.18%
Upgrade
FCF Yield
-16.16%-15.66%-41.45%-13.80%-1.05%-3.56%
Upgrade
Buyback Yield / Dilution
-6.22%-6.22%-16.48%-6.56%-25.86%-12.28%
Upgrade
Updated Feb 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q